Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 12, 2009, Pages 1493-1501

  Gajewski, James L ^a   LeMaistre, C Frederick ^b   Silver, Samuel M ^c   Lill, Michael C ^d   Selby, George B ^e   Horowitz, Mary M ^f   Rizzo, J Douglas ^f   Heslop, Helen E ^g   Anasetti, Claudio ^h   Maziarz, Richard T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b TEXAS TRANSPLANT INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g HOUSTON METHODIST HOSPITAL   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PERSONNEL MANAGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIFESTYLE; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL SCHOOL; MEDICAL SPECIALIST; MEDICAL TECHNOLOGIST; MULTIPLE MYELOMA; NURSE; PHARMACIST; PRIMARY MEDICAL CARE; RESIDENCY EDUCATION; SURVIVAL RATE; SURVIVOR; TREATMENT OUTCOME;

EID: 70350475710     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.08.022     Document Type: Note

References (41)

1. Applebaum F.R. The current status of hematopoietic cell transplantation. Annu Rev Med 54 (2003) 491-512
2. Ferrara J.L.M., Anasetti C., Stadtmauer E., et al. Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Biol Blood Marrow Trans 13 (2007) 1268-1285
3. Erikson C., Salsberg E., Forte G., et al. Future supply and demand for oncologists challenges to assuring access to oncology services. J Oncol Pract 3 (2007) 79-86
4. Warren J.L., Mariotto A.B., Meekins A., et al. Current and future utilization of services from medical oncologists. J Clin Oncol 26 (2008) 3242-3247
5. Aschan J. Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Br Med Bull 77-78 (2006) 23-36
6. Attal M., Harousseau J., Stoppa A., et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335 (1996) 91-97
7. Giralt S. Allografting older patients: myths and realities. Biol Blood Marrow Transplant 15 1 Suppl (2008) 146-148
8. Champlin R., Khouri I., Anderlini P., et al. Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation: biology and current indications. Oncology (Williston Park) 17 (2003) 94-100
9. Ferrara J.L., Levine J.E., Reddy P., et al. Graft-versus-host disease. Lancet 373 (2009) 1550-1561
10. Petersdorf E.W., Longton G.M., Anasetti C., et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, -B, -DR-identical unrelated donor marrow transplantation. Blood 86 (1995) 1606-1613
11. Majhail N.S., Brunstein C.G., Tomblyn M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 14 (2008) 282-289
12. Baron F., Storb R., Storer B.E., et al. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. J Clin Oncol 24 (2006) 4150-4157
13. Mattsson J. Recent progress in allogeneic stem cell transplantation. Curr Opin Mol Ther 10 (2008) 343-349
14. Center for International Blood and Marrow Transplant Research Newsletter, December 2007, page 1, slide 5. Available from: http://www.cibmtr.org/PUBLICATIONS/Newsletter/DOCS/2007Dec.pdf. Accessed August 24, 2009.
15. Gratwohl A., Baldomero H., Frauendorfer K., et al. Joint Accreditation Committee of the International Society for Cellular Therapy ISCT, European Group for Blood and Marrow Transplantation EMBT (JACIE). Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant 42 Suppl 1 (2008) S7-S10
16. Giralt S.A., Arora M., Goldman J.M., et al., for the Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. Br J Haematol 137 (2007) 461-467
17. Gratwohl A., Passweg J., Baldomero H., et al., Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 117 (2002) 451-468
18. Kollman C., Weis T., Switzer G.E., et al. Non-HLA barriers to unrelated donor stem cell transplantation. Bone Marrow Transplant 27 (2001) 581-587
19. Mitchell J.M., Meehan K.R., Kong J., et al. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol 15 (1997) 2644-2651
20. US Census Bureau. Health insurance coverage: 2007. Available from: http://www.census.gov/hhes/www/hlthins/hlthin07/hlth07asc.html. Accessed June 26, 2009.
21. Gajewski J.L., and Robinson P. Do affluent societies have the only options for the best therapy?. Leukemia 21 (2007) 387-388
22. Nietfeld J.J., Pasquini M.C., Logan B.R., et al. Lifetime probabilities of hematopoietic stem cell transplantation in the US. Biol Blood Marrow Transplant 14 (2008) 316-322
23. Council on Graduate Medical Education. Physician Workforce Policy Guidelines for the United States, 2000-2020. Available from: http://www.cogme.gov/report16.htm#future. Accessed June 16, 2009.
24. US Census Bureau. National population projections, released 2008 (based on Census 2000). Available from: http://www.census.gov/population/www/projections/summarytables.html. Accessed June 16, 2009.
25. National Marrow Donor Program. 2008 report to the community. Available from: http://www.marrow.org/ABOUT/Who_We_Are/Publications/index.html. Accessed June 23, 2009.
26. Karanes C., Nelson G.O., Chitphakdithai P., et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 14 9 Suppl (2008) 8-15
27. National Marrow Donor Program. Trends in allogeneic transplant. Available from: http://www.marrow.org/PHYSICIAN/URD_Search_and_Tx/Number_of_Allogeneic_Tx_Perfor/index.html#transplant. Accessed June 16, 2009.
28. Lara Jr. P.N., Higdon R., Lim N., et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19 (2001) 1728-1733
29. Simoens S, Hurst J. The supply of physician services in OECD countries. Organization for Economic Cooperation and Development Health Working Papers. Available from: http://www.oecd.org/dataoecd/27/22/35987490.pdf. Accessed June 16, 2009.
30. Salsberg E., and Grover A. Physician workforce shortages: implications and issues for academic health centers and policymakers. Acad Med 81 (2006) 782-787
31. Blumenthal D. New steam from an old cauldron: the physician supply debate. N Engl J Med 350 (2004) 1780-1787
32. Sox H.C. Leaving internal medicine. Ann Intern Med 144 (2006) 57-58
33. Cooper R.A. There's a shortage of specialists: is anyone listening?. Acad Med 77 (2002) 761-766
34. Starfield B., and Fryer Jr. G.E. The primary care physician workforce: ethical and policy implications. Ann Fam Med 5 (2007) 486-491
35. American Association of College of Nurses. Nursing shortage fact sheet. Available from: http://www.aacn.nche.edu/Media/pdf/NrsgShortageFS.pdf. Accessed June 16, 2009.
36. Jones Jr. M.D., McGuinness G.A., First L.R., et al. Residency Review and Redesign in Pediatrics Committee. Linking process to outcome: are we training pediatricians to meet evolving health care needs?. Pediatrics 123 Suppl 1 (2009) S1-S7
37. David A.K. Preparing the personal physician for practice (P(4)): residency training in family medicine for the future. J Am Board Fam Med 20 (2007) 332-341
38. Association of American Medical Colleges. Total US medical school enrollment by race and ethnicity within sex, 2003-2008. Available from: http://www.aamc.org/data/facts/2008/enrllbyraceeth0308.htm. Accessed June 16, 2009.
39. Potee R.A., Gerber A.J., and Ickovics J.R. Medicine and motherhood: shifting trends among female physicians from 1922 to 1999. Acad Med 74 (1999) 911-919
40. Watson D.E., Slate S., Buske L., et al. Intergenerational differences in workloads among primary care physicians: a ten-year, population-based study. Health Affairs 25 (2006) 1620-1628
41. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 13 (2007) 1461-1468